PHARMACHEMIE BV
GenericsPHARMACHEMIE BV is a generic drug manufacturer focused on Oncology, Immunology.
PHARMACHEMIE BV's Key Drugs
PHARMACHEMIE BV's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PHARMACHEMIE BV's Recent FDA Approvals
New NDA/BLA approvals for PHARMACHEMIE BV over the last two years — novel drugs only, excluding generics and label supplements.
PHARMACHEMIE BV's Therapeutic Areas
PHARMACHEMIE BV's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Immunology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PHARMACHEMIE BV's Top Competitors
PHARMACHEMIE BV's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PHARMACHEMIE BV Pipeline Snapshot
Active clinical trials for PHARMACHEMIE BV across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1990-05-21
- Latest
- 2026-01-14
- Applications
- 8